In Vitro Evaluation of GLP-1R-Associated Activity of a Sustainable Standardized Phospholipid-Formulated Bergamot Extract. [PDF]
Khan A +8 more
europepmc +1 more source
A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study (Biomedical Research in Severe Asthma). [PDF]
Domínguez-Ortega J +10 more
europepmc +1 more source
Targeting Neuropeptide Y/DPP4 Signalling Suppresses Ewing Sarcoma Survival and Improves Monocyte Viability. [PDF]
Rumney RMH, Górecki DC.
europepmc +1 more source
Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS). [PDF]
Xiong W, Li Y, Huang J, He G, Sun J.
europepmc +1 more source
DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy. [PDF]
Ming-Kuen Tang P +6 more
europepmc +1 more source
<i>Ferula gummosa</i> in colorectal cancer: a bioinformatics and experimental validation study. [PDF]
Alibakhshi A +7 more
europepmc +1 more source
Integrative biology shows DPP4 affects inflammatory response to eclampsia and cell model growth via p65/NLRP3/ASC/Caspase-1 pathway. [PDF]
Bian Z, Hao L, Yang R, Sun J.
europepmc +1 more source
Identification of Prohibitin (PHB) as an Entry Factor of Highly Pathogenic Coronaviruses Using Metabolic Glycoengineering and Photo-Crosslinking Techniques. [PDF]
Zhu X +13 more
europepmc +1 more source
Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4. [PDF]
Chen N +9 more
europepmc +1 more source
Retraction Notice to: DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy. [PDF]
Ming-Kuen Tang P +6 more
europepmc +1 more source

